• Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methixyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride. Patients who responded to clomipramine treatment had significantly higher CSF levels of 5-HIAA before treatment. The amelioration of obsessive-compulsive symptoms was positively correlated to the reduction of CSF concentrations of 5-HIAA during clomipramine treatment but negatively correlated to plasma concentrations of clomipramine. Reduction of CSF concentrations of 5-HIAA, which probably reflects drug action on central serotonin neurons, was maximal at a plasma clomipramine concentration of about 300 nmole/L. At higher levels, the reduction of CSF levels of 5-HIAA was smaller. The antiobsessive effect of clomipramine may be connected to its capacity to inhibit serotonin uptake.
Thorän P, Åsberg M, Bertilsson L, Mellstrüm B, Sjüqvist F, Träskman L. Clomipramine Treatment of Obsessive-Compulsive Disorder: II. Biochemical Aspects. Arch Gen Psychiatry. 1980;37(11):1289–1294. doi:10.1001/archpsyc.1980.01780240087010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.